Denosumab stalls skeletal-related events in breast ca: Time to a first event was 5 months longer than with zoledronic acid and to hypercalcemia, 7 months - Commentary

Charles L. Loprinzi

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Denosumab stalls skeletal-related events in breast ca: Time to a first event was 5 months longer than with zoledronic acid and to hypercalcemia, 7 months - Commentary'. Together they form a unique fingerprint.